Menu Search
Equities

MW Trade SA

0O9L:LSE

MW Trade SA

Actions
  • Price (PLN)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

M.W. Trade SA is a Poland-based company that specializes in the financial and advisory support for the benefit of independent public healthcare units. The Company's services include solutions allowing for complete restructuring of liabilities, investments’ financing and assistance in adapting hospitals to the newest requirements related to the expectations of the European Union, among others. The Company provides services, such as Hospital Fund that helps the hospital to secure financial liquidity and minimizes cost connected with debt. It focuses mainly on the outstanding civil (non-governmental) liabilities. The Company's operations also include support for charities and aid in modernizing hospitals. As of December 31, 2011, Getin Holding SA held a 51.27% stake in the Company.

  • Revenue in PLN (TTM)502.00k
  • Net income in PLN-2.76m
  • Incorporated2007
  • Employees8.00
  • Location
    MW Trade SAul. Powstancow Slaskich 125/200WROCLAW 53-317PolandPOL
  • Phone+48 717902050
  • Fax+48 717902055
  • Websitehttp://www.mwtrade.pl/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.